Summary
The aim of the present study was to compare the ability of different doses of isosorbide-5-mononitrate (5-ISMN) to cause dilatation of medium sized and small arteries, and to examine the intensity and duration of any headache produced. Ten healthy volunteers each received 3 doses of 5-ISMN and placebo on separate days. The diameters of the radial and superficial temporal arteries were repeatedly measured with high frequency ultrasound and pain was scored using a 10 point verbal scale.
A clear dose-relationship was found for plasma concentrations and headache, and for changes in the diameter of the temporal artery, but not for the radial artery.
It is concluded that headache after 5-ISMN is caused by arterial dilatation or by mechanisms responsible for the arterial dilatation. Ultrasound monitoring of arterial diameters is an important and sensitive tool in the evaluation of nitrates and other vasodilators.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fletcher A, McLoone P, Bulpitt C (1988) Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet II: 4–8
Thadani U, Hamilton SF, Olson E, Anderson JL, Prasad R, Voyles W, Doyle R, Kirsten E, Teague SM (1987) Duration of effects and tolerance of slow-release Isosorbide-5-Mononitrate for angina pectoris. Am J Cardiol 59: 756–762
Iversen HK, Olesen J, Tfelt-Hansen P (1989) Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38: 17–24
Abshagen U, Sporl-Radun S (1981) First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man. Eur J Clin Pharmacol 19: 423–429
Abshagen U (1985) Pharmacokinetics of ISDN, sustained release ISDN and IS-5-MN. In: Cohn JN, Rittinghausen R (eds) Mononitrates. Springer, Berlin Heidelberg New York, pp 53–66
Nielsen TH, Iversen HK, Tfelt-Hansen P (1990) Determination of the luminal diameter of the radial artery in man by high frequency ultrasound. A methodological study. Ultrasound Med Biol 8: 787–791
Armitage P, Berry G (1985) Statistical methods in medical research. Blackwell Scientific, Oxford London, pp 200–205
Andersen B, Holm P (1984) Problems with P. Significance testing in Medical Research. Roche, Denmark
Fricke G, Hild R, Ihm P, Modlmayr HH (1976) Feldstudie mit Isoket und Isoket retard. In: Siegenthaler RW (Hrsg) Nitrate, Wirkung auf Herz und Kreislauf. Urban & Schwarzenberg, München Berlin Wien, S 151–160
Thadani U, Prasad R, Hamilton SF, Voyles W, Doyle R, Karpow S, Reder R, Teague SM (1987) Usefulness of twice daily Isosorbide-5-Mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol 60: 477–482
Ahlner J, Axelsson KL (1987) Nitrates mode of action at a cellular level. Drugs 33 [Suppl 4]: 32–38
Bartsch W, Strein K, Böhm E, Sponer G, Müller-Beckmann B (1985) Isosorbide-5-mononitrate increases cyclic guanocine mono-phosphate concentration in rat aorta in vitro and in vivo. In: Cohn JN, Rittinghausen R (eds) Mononitrates. Springer, Berlin Heidelberg New York, pp 34–38
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain (1988) Cephalalgia 8 [Suppl 7]: 19–28
Olesen J, Paulson OB (1971) The effect of intra-arterial papaverine on the regional cerebral blood flow in patients with stroke or intracranial tumors. Stroke 2: 148–159
Simon AC, Levenson JA, Levy BY, Bouthier JE, Peronneau PP, Safar ME (1982) Effect of nitroglycerin on pheripheral large arteries in hypertension. Br J Clin Pharmacol 14: 241–246
Iversen HK, Nielsen TH, Tfelt-Hansen P, Olesen J (1989) Headache and changes in the diameter of the radial artery during 7 hours intravenous nitroglycerin infusion. Cephalalgia 9 [Suppl 10]: 82–83
Schnaar R, Sparks HV (1972) Response of large and small coronary arteries to nitroglycerin, NaNO2, and adenosine. Am J Physiol 1: 223–228
Forster C, Main JS, Armstrong PW (1990) Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure. Br J Pharmacol 101: 109–114
Abshagen U, Betzien G, Endele R, Kaufmann B (1981) Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate. Eur J Clin Pharmacol 20: 269–275
Jonsson UE (1987) Various administration forms of nitrates and their possibilities. Drugs 33 [Suppl 4]: 23–31
Tauchert M, Jansen W, Osterspey A et al. (1983) Dose dependence of tolerance during treatment with mononitrates. Z Kardiol 72 [Suppl 3]: 218–228
Yokota M, Tsunekawa A, Miyahara T et al. (1986) Effect of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris. Am J Cardiol 58: 53–58
Kenedi P, Gathmann-Lewik U (1987) Dose-effect relationship amongst three different sustained-release forms of isosorbid-5-mononitrat in patients with coronary artery disease. Cardiology 74 [Suppl 1]: 29–33
Imhof PR, Rennwald D, Müller P, Howald H, Burkart F (1989) Circulatory counter-regulations induced by continuous administration of nitroglycerin. Meth Find Exp Clin Pharmacol 11: 409–414
Nabel E, Selwyn AP, Ganz P (1990) Large coronary arteries in humans are responsive to changing blood flow: an endothelium dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 16: 349–356
Akpan W, Endele R, Neugebauer G, Steudel H (1985) Pharmacokinetics of IS-5-MN after oral and intravenous administration in patients with hepatic failure. In: Cohn JN, Rittinghausen R (eds) Mononitrates. Springer, Berlin Heidelberg New York, pp 86–91
Raue F, Ritz E, Akpan W, Endele R, Neugebauer G (1985) Kinetics of IS-5-MN and its glucuronide in patients with renal failure. In: Cohn JN, Rittinghausen R (eds) Mononitrates. Springer, Berlin Heidelberg New York, pp 78–85
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iversen, H.K., Nielsen, T.H., Garre, K. et al. Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol 42, 31–35 (1992). https://doi.org/10.1007/BF00314916
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314916